Home › Approval of breast cancer treatment triggers $5M payment to Immunogen
 

Keywords :   


Approval of breast cancer treatment triggers $5M payment to Immunogen

2013-09-20 21:16:15| Biotech - Topix.net

Immunogen Inc., led by CEO Daniel Junius, has received a $5M milestone payment for its role in Kadcyla receiving approval in Japan.

Tags: to treatment payment approval

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
14.11DX&DX
14.111973
14.11Grand Prix 5000 S TR 25C
14.11PUMA Z 1.2 FG/AG FIRST MILE
14.11.45
14.1163
14.11DVD18
14.11THEE MICHELLE GUN ELEPHANT
More »